MICRORNA-1297 IS INVOLVED IN THE RESISTANCE OF LENVATINIB IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Kogure, Takayuki [1 ]
Satoh, Mari [1 ,2 ]
Ito, Takehito [3 ]
Satoh, Kennichi [1 ]
机构：
[1] Tohoku Med & Pharmaceut Univ, Sendai, Miyagi, Japan
[2] Tome City Toyosato Hosp, Tome City, Italy
[3] Tohoku Med & Pharmaceut Univ, Wakabayashi Hosp, Sendai, Miyagi, Japan
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4205-A
引用
收藏
页码：S1944 / S1945
页数：2
相关论文
共 50 条
  • [1] MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2
    Liu, Fenghua
    He, Yukai
    Shu, Ronghua
    Wang, Sikui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 4972 - 4980
  • [2] MicroRNA-1297 contributes to the progression of human cervical carcinoma through PTEN
    Chen, Zhihua
    Zhang, Mengzhen
    Qiao, Yuhuan
    Yang, Junjuan
    Yin, Qinan
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 1120 - 1126
  • [3] microRNA-1297 involves in the progression of oral squamous cell carcinoma through PTEN
    Liang, Limin
    Feng, Lin
    Wei, Bo
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2018, 25 (05) : 923 - 927
  • [4] MICRORNA-491-5p IS INVOLVED IN THE RESISTANCE TO LENVATINIB INDUCED UNDER HYPOXIA IN HEPATOCELLULAR CARCINOMA
    Satoh, Mari
    Kogure, Takayuki
    Ito, Takehito
    Takahashi, Masanori
    Ouchi, Ryusuke
    Usui, Kensuke
    Okada, Kouji
    Satoh, Kennichi
    HEPATOLOGY, 2021, 74 : 702A - 702A
  • [5] Resistance of Lenvatinib in Hepatocellular Carcinoma
    Guo, Jinhui
    Zhao, Junjun
    Xu, Qiuran
    Huang, Dongsheng
    CURRENT CANCER DRUG TARGETS, 2022, 22 (11) : 865 - 878
  • [6] IDENTIFICATION OF microRNAs INVOLVED IN RESISTANCE OF LENVATINIB UNDER HYPOXIA IN HEPATOCELLULAR CARCINOMA
    Satoh, Mari
    Kogure, Takayuki
    Ito, Takehito
    Takahashi, Masanori
    Usui, Kensuke
    Okada, Kouji
    Satoh, Kennichi
    HEPATOLOGY, 2023, 78 : S1990 - S1991
  • [7] Dual role of microRNA-1297 in the suppression and progression of human malignancies
    Alizadeh-Fanalou, Shahin
    Khosravi, Mohsen
    Alian, Fatemeh
    Rokhsartalb-Azar, Shirin
    Nazarizadeh, Ali
    Karimi-Dehkordi, Maryam
    Mohammadi, Forogh
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [8] Increased c-SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma
    Takahashi, Masamitsu
    Araki, Takuya
    Yashima, Hideaki
    Nagamine, Ayumu
    Nagano, Daisuke
    Yamamoto, Koujirou
    ONCOLOGY LETTERS, 2023, 26 (06)
  • [9] Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
    Tao, Meng
    Han, Jing
    Shi, Juanyi
    Liao, Hao
    Wen, Kai
    Wang, Weidong
    Mui, Sintim
    Li, Huoming
    Yan, Yongcong
    Xiao, Zhiyu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1069 - 1083
  • [10] EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
    Xiaoping He
    Yohko Hikiba
    Yoshimasa Suzuki
    Yoshinori Nakamori
    Yushi Kanemaru
    Makoto Sugimori
    Takeshi Sato
    Akito Nozaki
    Makoto Chuma
    Shin Maeda
    Scientific Reports, 12
12345